Genentech applied for an SPC in February 2007 to cover the compound Ranibizumab. Ranibizumab is a key constituent of the drug Lucentis which treats “wet” macular degeneration - an eye condition, which causes age-related vision loss.
These are unprecedented times for all businesses, with pressure to adapt to a constantly evolving ‘new normal’. With challenges to address on multiple fronts, here are four areas of focus to help ensure your intellectual property approach is aligned to your immediate business priorities.
This year we celebrate World Intellectual Property Day under different and somewhat unusual circumstances. As the majority of schools remain closed due to the coronavirus outbreak, we felt it was only appropriate to involve your children on this special and important day.
In a case brought by established travel agency, Trailfinders, the High Court has for the first time considered the application of the so-called Trade Secrets Directive, which was implemented into UK law in June 2018.
The future of the Unified Patent Court was dealt a further setback last week by a judgment in the German Federal Constitutional Court.
At this time of international worry and concern over COVID-19, Potter Clarkson appreciates the increasing disruption to all our usual lives - both in business and in the home. Our thoughts are with those who have been personally affected around the world.